
GeoVax Labs, Inc. – NASDAQ:GOVXW
GeoVax Labs stock price today
GeoVax Labs stock price monthly change
GeoVax Labs stock price quarterly change
GeoVax Labs stock price yearly change
GeoVax Labs key metrics
Market Cap | 25.66M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -14.45 |
Revenue | N/A |
EBITDA | -28.27M |
Income | -27.77M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -22925.62% |
Oper. margin | -22936.36% |
Gross margin | 0% |
EBIT margin | -22936.36% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeGeoVax Labs stock price history
GeoVax Labs stock forecast
GeoVax Labs financial statements
Jun 2023 | 0 | -5.92M | |
---|---|---|---|
Sep 2023 | 0 | -8.40M | |
Dec 2023 | 103.91K | -7.59M | -7306.57% |
Mar 2024 | 0 | -5.85M |
Jun 2023 | 21249062 | 4.08M | 19.23% |
---|---|---|---|
Sep 2023 | 16201031 | 7.08M | 43.71% |
Dec 2023 | 9283219 | 3.51M | 37.92% |
Mar 2024 | 3358182 | 3.30M | 98.38% |
Jun 2023 | -6.03M | -23.80K | 0 |
---|---|---|---|
Sep 2023 | -5.09M | -6.19K | 0 |
Dec 2023 | -10.27M | -18.94K | 4.06M |
Mar 2024 | -5.68M | 0 | 0 |
GeoVax Labs alternative data
Jan 2024 | 14 |
---|---|
Feb 2024 | 14 |
Mar 2024 | 17 |
Apr 2024 | 17 |
May 2024 | 17 |
Jun 2024 | 17 |
Jul 2024 | 17 |
GeoVax Labs other data
-
What's the price of GeoVax Labs stock today?
One share of GeoVax Labs stock can currently be purchased for approximately $0.02.
-
When is GeoVax Labs's next earnings date?
Unfortunately, GeoVax Labs's (GOVXW) next earnings date is currently unknown.
-
Does GeoVax Labs pay dividends?
No, GeoVax Labs does not pay dividends.
-
How much money does GeoVax Labs make?
GeoVax Labs has a market capitalization of 25.66M.
-
What is GeoVax Labs's stock symbol?
GeoVax Labs, Inc. is traded on the NASDAQ under the ticker symbol "GOVXW".
-
What is GeoVax Labs's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of GeoVax Labs?
Shares of GeoVax Labs can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does GeoVax Labs have?
As Jul 2024, GeoVax Labs employs 17 workers.
-
What is GeoVax Labs's official website?
The official website for GeoVax Labs is geovax.com.
-
How can i contact GeoVax Labs?
GeoVax Labs can be reached via phone at +678 3847220.
GeoVax Labs company profile:

GeoVax Labs, Inc.
geovax.comNASDAQ
17
Biotechnology
Healthcare
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company is developing GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, it is also developing GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-MM02 treatment for malaria; GEO-EM01 for the treatment of fever viruses, such as Ebola, Sudan, and Marburg; GEO-LM01 for the treatment of Lassa fever. GeoVax Labs, Inc. has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; U.S. Department of Defense; Emory University; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is headquartered in Smyrna, Georgia.
Smyrna, 30080
CIK: 0000832489
ISIN: US3736781192
CUSIP: 373678119